Ritter Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public, Subsidiary
- Established
- 2004-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://ritterpharma.com
Clinical Trials
4
Active:0
Completed:4
Trial Phases
3 Phases
Phase 1:1
Phase 2:2
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (50.0%)Phase 1
1 (25.0%)Phase 3
1 (25.0%)Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
- First Posted Date
- 2018-07-24
- Last Posted Date
- 2019-07-08
- Lead Sponsor
- Ritter Pharmaceuticals, Inc.
- Target Recruit Count
- 557
- Registration Number
- NCT03597516
- Locations
- 🇺🇸
Research Facility, Miami, Florida, United States
🇺🇸Research Site, Bellevue, Washington, United States
🇺🇸Reseaarch Site, Pompano Beach, Florida, United States
Effect of a Standard Meal on the Pharmacokinetic Profile of RP-G28 in Healthy Adult Male and Female Subjects
- First Posted Date
- 2018-06-20
- Last Posted Date
- 2018-08-08
- Lead Sponsor
- Ritter Pharmaceuticals, Inc.
- Target Recruit Count
- 14
- Registration Number
- NCT03563846
- Locations
- 🇺🇸
Syneos Health, Miami, Florida, United States
Efficacy, Safety, and Tolerability Study of RP-G28 in Subjects With Lactose Intolerance
- First Posted Date
- 2016-02-04
- Last Posted Date
- 2018-04-04
- Lead Sponsor
- Ritter Pharmaceuticals, Inc.
- Target Recruit Count
- 377
- Registration Number
- NCT02673749
- Locations
- 🇺🇸
Covance, Inc., Princeton, New Jersey, United States
Effectiveness, Safety and Tolerability Study of RP-G28 for Symptoms Associated With Lactose Intolerance
Phase 2
Completed
- Conditions
- Lactose Intolerance
- Interventions
- Drug: RP-G28 or placebo
- First Posted Date
- 2010-04-30
- Last Posted Date
- 2011-12-08
- Lead Sponsor
- Ritter Pharmaceuticals, Inc.
- Target Recruit Count
- 61
- Registration Number
- NCT01113619
- Locations
- 🇺🇸
Covance, Inc. - Honolulu, Honolulu, Hawaii, United States
🇺🇸Covance, Inc. - Dallas, Dallas, Texas, United States
News
No news found